Figure S6 from Combination Therapies Targeting ALK-aberrant Neuroblastoma in Preclinical Models door Elizabeth R. Tucker (15053624)

Andere auteurs:

Figure S2 from Combination Therapies Targeting ALK-aberrant Neuroblastoma in Preclinical Models door Elizabeth R. Tucker (15053624)

Andere auteurs:

Figure S5 from Combination Therapies Targeting ALK-aberrant Neuroblastoma in Preclinical Models door Elizabeth R. Tucker (15053624)

Andere auteurs:

Figure S1 from Combination Therapies Targeting ALK-aberrant Neuroblastoma in Preclinical Models door Elizabeth R. Tucker (15053624)

Andere auteurs:

Figure S4 from Combination Therapies Targeting ALK-aberrant Neuroblastoma in Preclinical Models door Elizabeth R. Tucker (15053624)

Andere auteurs:

Figure S3 from Combination Therapies Targeting ALK-aberrant Neuroblastoma in Preclinical Models door Elizabeth R. Tucker (15053624)

Andere auteurs: